ARCHIVES

NCI Awards $6.7 Million For Breast Cancer Research.

This article is from The Cancer Letter archive.

Vol. 26 No. 32 | September 8, 2000

Download PDF Visit The Full Archive

Related Articles

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees

July 29, 1988

Alan Rabson Named Acting NCI Director

October 5, 2001

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993